Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,663.20
(
-0.24%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
106.84
(
2.30%
)
Bitcoin
70,629.00
(
1.04%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: genisi post# 153409

Tuesday, 12/04/2012 10:28:58 PM

Tuesday, December 04, 2012 10:28:58 PM

Post# of 257262

So, I think it's quite possible that GILD's NS5A GS-5885 can produce similar results.




Two weeks ago GILD added Arm-17, and Arm-18 to this ongoing study. So testing of Sofosbuvir/GS-5885 and Sofosbuvir/5885/riba in GT2/GT3 has begun.



http://clinicaltrials.gov/ct2/show/NCT01260350?term=gs-5885&rank=10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now